Literature DB >> 1562280

Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen.

A Noel1, N Simon, J Raus, J M Foidart.   

Abstract

The ability to transplant human tumors into athymic nude mice allows studies of tumor cells in vivo. However, after s.c. injection the incidence of tumor and metastases in nude mice is frequently low. We have studied the tumorigenicity in nude mice of estradiol (E2)-sensitive breast adenocarcinoma MCF7 cells. Matrigel, an extract of basement membrane proteins, induces rapid tumor development after s.c. injection of MCF7 cells. In the absence of this matrice, MCF7 cells failed to induce tumor growth. In this in vivo model, MCF7 cells were analysed for their E2 sensitivity. Two weeks after inoculation in the presence of matrigel, cells formed growing tumors in intact mice supplemented with E2. In ovariectomized or untreated mice, tumor appearance was delayed and the growth level was very low. Thus, MCF7 cells formed tumors in the absence of E2 but retained in vivo their responsiveness to estrogen. Growing human tumors in nude mice provides a rapid and useful model for testing the sensitivity of cells to hormone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562280     DOI: 10.1016/0006-2952(92)90501-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Authors:  Christine M Fillmore; Piyush B Gupta; Jenny A Rudnick; Silvia Caballero; Patricia J Keller; Eric S Lander; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Building a Functional Salivary Gland for Cell-Based Therapy: More than Secretory Epithelial Acini.

Authors:  Caitlynn M L Barrows; Danielle Wu; Mary C Farach-Carson; Simon Young
Journal:  Tissue Eng Part A       Date:  2020-09-21       Impact factor: 3.845

Review 3.  The role of stroma in breast carcinoma growth in vivo.

Authors:  A Noël; J M Foidart
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

4.  Stromelysin-3 expression promotes tumor take in nude mice.

Authors:  A C Nöel; O Lefebvre; E Maquoi; L VanHoorde; M P Chenard; M Mareel; J M Foidart; P Basset; M C Rio
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

5.  Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.

Authors:  Trivia Frazier; Christopher Williams; Michael Henderson; Tamika Duplessis; Emma Rogers; Xiying Wu; Katie Hamel; Elizabeth C Martin; Omair Mohiuddin; Shahensha Shaik; Ram Devireddy; Brian G Rowan; Daniel J Hayes; Jeffrey M Gimble
Journal:  Tissue Eng Part A       Date:  2021-03-10       Impact factor: 3.845

6.  PET Imaging of Estrogen Receptors Using 18F-Based Radioligands.

Authors:  Manoj Kumar; Kelley Salem; Justin J Jeffery; Amy M Fowler
Journal:  Methods Mol Biol       Date:  2022

Review 7.  A new hypothesis for the cancer mechanism.

Authors:  Xiaolong Meng; Jie Zhong; Shuying Liu; Mollianne Murray; Ana M Gonzalez-Angulo
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

8.  Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts.

Authors:  A Noël; M C De Pauw-Gillet; G Purnell; B Nusgens; C M Lapiere; J M Foidart
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

9.  Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice.

Authors:  P Topley; D C Jenkins; E A Jessup; J N Stables
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

Authors:  H J van Slooten; B A Bonsing; A J Hiller; G T Colbern; J H van Dierendonck; C J Cornelisse; H S Smith
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.